Department of Pediatrics, Yale University School of Medicine and Graduate School of Arts and Sciences, New Haven, Connecticut 06520-8064, USA.
J Infect Dis. 2011 Feb 1;203(3):312-5. doi: 10.1093/infdis/jiq052.
Because of ongoing outbreaks of varicella, a second dose of varicella vaccine was added to the routine immunization schedule for children in June 2006 by the Centers for Disease Control and Prevention.
We assessed the effectiveness of 2 doses of varicella vaccine in a case-control study by identifying children ≥4 years of age with varicella confirmed by polymerase chain reaction assay and up to 2 controls matched by age and pediatric practice. Effectiveness was calculated using exact conditional logistic regression.
From July 2006 to January 2010, of the 71 case subjects and 140 matched controls enrolled, no cases (0%) vs 22 controls (15.7%) had received 2 doses of varicella vaccine, 66 cases (93.0%) vs 117 controls (83.6%) had received 1 dose, and 5 cases (7.0%) vs 1 control (0.7%) did not receive varicella vaccine (P < .001). The effectiveness of 2 doses of the vaccine was 98.3% (95% confidence level [CI]: 83.5%-100%; P < .001). The matched odds ratio for 2 doses vs 1 dose of the vaccine was 0.053 (95% CI: 0.002-0.320; P < .001).
The effectiveness of 2 doses of varicella vaccine in the first 2.5 years after recommendation of a routine second dose of the vaccine for children is excellent. Odds of developing varicella were 95% lower for children who received 2 doses compared with 1 dose of varicella vaccine.
由于水痘的持续爆发,疾病预防控制中心在 2006 年 6 月将水痘疫苗的第二剂纳入儿童常规免疫计划。
我们通过聚合酶链反应检测鉴定≥4 岁的儿童水痘确诊病例,并将其与年龄和儿科实践相匹配的最多 2 名对照进行病例对照研究,评估了两剂水痘疫苗的效果。使用精确条件逻辑回归计算有效性。
从 2006 年 7 月到 2010 年 1 月,在纳入的 71 例病例和 140 例匹配对照中,0 例(0%)vs 22 例(15.7%)接受了两剂水痘疫苗,66 例(93.0%)vs 117 例(83.6%)接受了一剂,5 例(7.0%)vs 1 例(0.7%)未接种水痘疫苗(P<0.001)。两剂疫苗的有效性为 98.3%(95%置信区间[CI]:83.5%-100%;P<0.001)。两剂与一剂疫苗的匹配比值比为 0.053(95%CI:0.002-0.320;P<0.001)。
推荐儿童常规接种第二剂水痘疫苗后 2.5 年内,两剂水痘疫苗的有效性非常好。与一剂水痘疫苗相比,接受两剂疫苗的儿童患水痘的几率降低了 95%。